CrestPoint Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-3,800
| Closed | -$533K | – | 225 |
|
|
2017
Q3 | $533K | Sell |
3,800
-200
| -5% | -$28.1K | 0.24% | 142 |
|
|
2017
Q2 | $487K | Buy |
+4,000
| New | +$487K | 0.23% | 143 |
|
|
2016
Q4 | – | Sell |
-2,400
| Closed | -$294K | – | 232 |
|
|
2016
Q3 | $294K | Sell |
2,400
-100
| -4% | -$12.3K | 0.15% | 183 |
|
|
2016
Q2 | $292K | Hold |
2,500
| – | – | 0.16% | 172 |
|
|
2016
Q1 | $348K | Buy |
2,500
+200
| +9% | +$27.8K | 0.19% | 158 |
|
|
2015
Q4 | $439K | Hold |
2,300
| – | – | 0.25% | 124 |
|
|
2015
Q3 | $360K | Buy |
+2,300
| New | +$360K | 0.21% | 145 |
|
|
2015
Q1 | – | Sell |
-1,200
| Closed | -$222K | – | 254 |
|
|
2014
Q4 | $222K | Sell |
1,200
-100
| -8% | -$18.5K | 0.12% | 210 |
|
|
2014
Q3 | $216K | Sell |
1,300
-2,000
| -61% | -$332K | 0.13% | 201 |
|
|
2014
Q2 | $516K | Buy |
3,300
+400
| +14% | +$62.5K | 0.3% | 117 |
|
|
2014
Q1 | $441K | Hold |
2,900
| – | – | 0.27% | 127 |
|
|
2013
Q4 | $385K | Buy |
+2,900
| New | +$385K | 0.25% | 131 |
|